FR2341317B1 - - Google Patents

Info

Publication number
FR2341317B1
FR2341317B1 FR7604443A FR7604443A FR2341317B1 FR 2341317 B1 FR2341317 B1 FR 2341317B1 FR 7604443 A FR7604443 A FR 7604443A FR 7604443 A FR7604443 A FR 7604443A FR 2341317 B1 FR2341317 B1 FR 2341317B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7604443A
Other languages
French (fr)
Other versions
FR2341317A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DERMAL LAB Ltd
Original Assignee
DERMAL LAB Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DERMAL LAB Ltd filed Critical DERMAL LAB Ltd
Publication of FR2341317A1 publication Critical patent/FR2341317A1/fr
Application granted granted Critical
Publication of FR2341317B1 publication Critical patent/FR2341317B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7604443A 1975-02-19 1976-02-18 Compositions a base de steroides Granted FR2341317A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7030/75A GB1543907A (en) 1975-02-19 1975-02-19 Steroid compositions

Publications (2)

Publication Number Publication Date
FR2341317A1 FR2341317A1 (fr) 1977-09-16
FR2341317B1 true FR2341317B1 (sk) 1979-06-08

Family

ID=9825303

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7604443A Granted FR2341317A1 (fr) 1975-02-19 1976-02-18 Compositions a base de steroides

Country Status (7)

Country Link
JP (1) JPS609486B2 (sk)
AU (1) AU502937B2 (sk)
DE (1) DE2606516A1 (sk)
FR (1) FR2341317A1 (sk)
GB (1) GB1543907A (sk)
IE (1) IE43270B1 (sk)
ZA (1) ZA76980B (sk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
AT389447B (de) * 1983-01-27 1989-12-11 Taisho Pharmaceutical Co Ltd Verfahren zur herstellung einer topischen steroidsalbe
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
AU4472396A (en) * 1994-12-30 1996-07-24 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA725898B (en) * 1972-05-30 1973-05-30 Sackler R Iodophor steroid pharmaceutical compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation

Also Published As

Publication number Publication date
AU1123276A (en) 1977-08-25
IE43270B1 (en) 1981-01-28
FR2341317A1 (fr) 1977-09-16
IE43270L (en) 1976-08-19
DE2606516A1 (de) 1976-09-02
GB1543907A (en) 1979-04-11
JPS609486B2 (ja) 1985-03-11
ZA76980B (en) 1977-01-26
JPS51106713A (sk) 1976-09-21
AU502937B2 (en) 1979-08-16
DE2606516C2 (sk) 1987-09-17

Similar Documents

Publication Publication Date Title
FR2341317B1 (sk)
JPS5255353U (sk)
JPS5639123Y2 (sk)
JPS563438Y2 (sk)
JPS542236Y2 (sk)
JPS5437022Y2 (sk)
JPS5620249B2 (sk)
JPS5533593B2 (sk)
JPS5251637U (sk)
JPS51114112U (sk)
JPS5212466U (sk)
JPS51107007U (sk)
JPS5290182U (sk)
JPS51127746U (sk)
JPS5256960U (sk)
JPS5212143U (sk)
JPS5219927U (sk)
JPS5235300U (sk)
CH583020A5 (sk)
BG23448A1 (sk)
CH588700A5 (sk)
CH587513B5 (sk)
CH583052A5 (sk)
CH601743A5 (sk)
CH582441A5 (sk)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse